Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H4 | Q96RI1 | 19/20 | 0.54 |
| ▸ | LIFR | P42702 | 1/20 | 0.48 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | MAOB | P27338 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3640853 | 0.94 | NR1H4 (0.52) | NR1H4LIFRNR1I2CYP1A2CYP3A4 | |
| SCHEMBL3639176 | 0.92 | NR1H4 (0.64) | NR1H4LIFRNR1I2CYP1A2CYP3A4 | |
| SCHEMBL2812516 | 0.89 | NR1H4 (0.68) | NR1H4LIFRNR1I2CYP1A2CYP3A4 | |
| SCHEMBL3637835 | 0.85 | NR1H4 (0.62) | NR1H4LIFRNR1I2CYP1A2CYP3A4 | |
| SCHEMBL3637820 | 0.84 | NR1H4 (0.49) | NR1H4LIFRNR1I2CYP1A2CYP3A4 | |
| SCHEMBL2814161 | 0.83 | NR1H4 (0.65) | NR1H4LIFRNR1I2CYP1A2CYP3A4 | |
| SCHEMBL3637226 | 0.81 | NR1H4 (0.77) | NR1H4LIFRNR1I2CYP1A2CYP3A4 | |
| SCHEMBL4336044 | 0.81 | NR1H4 (0.67) | NR1H4LIFRNR1I2CYP1A2CYP3A4 | |
| SCHEMBL4339399 | 0.81 | NR1H4 (0.67) | NR1H4LIFRNR1I2CYP1A2CYP3A4 | |
| SCHEMBL4337491 | 0.80 | NR1H4 (0.65) | NR1H4LIFRNR1I2CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2170072-A1 | FARNESOID X RECEPTOR AGONISTS | GlaxoSmithKline LLC (US) | 2010-04-07 | — | — | EP | disclosed |
| WO-2008157270-A1 | FARNESOID X RECEPTOR AGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 2008-12-24 | — | — | WO | disclosed |